Jason Jones - Hiscox Group Director
| HSX Stock | 1,127 7.00 0.62% |
Director
Jason Jones is Group Director of Hiscox
| Address | Chesney House, Pembroke, Bermuda, HM 08 |
| Phone | 441 278 8300 |
| Web | https://www.hiscoxgroup.com |
Jason Jones Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jason Jones against Hiscox stock is an integral part of due diligence when investing in Hiscox. Jason Jones insider activity provides valuable insight into whether Hiscox is net buyers or sellers over its current business cycle. Note, Hiscox insiders must abide by specific rules, including filing SEC forms every time they buy or sell Hiscox'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jason Jones over six months ago Acquisition by Jason Jones of 12270 shares of Ekso Bionics subject to Rule 16b-3 |
Hiscox Management Efficiency
The company has return on total asset (ROA) of 0.0409 % which means that it generated a profit of $0.0409 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.232 %, meaning that it generated $0.232 on every $100 dollars invested by stockholders. Hiscox's management efficiency ratios could be used to measure how well Hiscox manages its routine affairs as well as how well it operates its assets and liabilities. At present, Hiscox's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 9.7 B, whereas Other Assets are projected to grow to (6.6 B).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Wenjie Wang | Sunny Optical Technology | 57 | |
| Yanfeng Liu | Sunny Optical Technology | N/A | |
| FRICS BSc | Primary Health Properties | N/A | |
| Nicholas Edwards | MyHealthChecked Plc | 54 | |
| Shelley Thomas | Spire Healthcare Group | N/A | |
| Jitesh Sodha | Spire Healthcare Group | 56 | |
| MRICS BSc | Primary Health Properties | N/A | |
| Rachel King | Spire Healthcare Group | N/A | |
| David Austin | Primary Health Properties | N/A | |
| Cathy Cale | Spire Healthcare Group | N/A | |
| Harbant Samra | Spire Healthcare Group | 45 | |
| Tony Willis | Sabien Technology Group | N/A | |
| BA ACA | Primary Health Properties | 59 | |
| Tony Coke | Primary Health Properties | N/A | |
| Lesley FCA | MyHealthChecked Plc | 66 | |
| Jesse Putzel | Primary Health Properties | N/A | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0409 |
Hiscox Leadership Team
Elected by the shareholders, the Hiscox's board of directors comprises two types of representatives: Hiscox inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hiscox. The board's role is to monitor Hiscox's management team and ensure that shareholders' interests are well served. Hiscox's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hiscox's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Regine Fiddler, Chief Officer | ||
| Marc Wetherhill, Group Secretary | ||
| Todd Isaac, Group Officer | ||
| Hamayou Hussain, Group Director | ||
| Nicola Grant, Chief Officer | ||
| Jason Jones, Group Director | ||
| Joanne Musselle, Group Director | ||
| Paul Cooper, Group Director | ||
| Kate Markham, Chief Market | ||
| Bronislaw Masojada, Chairman Asia | ||
| Kylie OConnor, Group Director | ||
| Yana OSullivan, Group Relations | ||
| Stephane Flaquet, Group Officer | ||
| James CFA, Chief Officer | ||
| Paul Lawrence, Chief 33 | ||
| Chris Loake, Group Officer |
Hiscox Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hiscox a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0409 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 3.33 B | ||||
| Shares Outstanding | 339.9 M | ||||
| Shares Owned By Insiders | 0.50 % | ||||
| Shares Owned By Institutions | 69.90 % | ||||
| Price To Book | 1.46 X | ||||
| Price To Sales | 1.03 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Hiscox Stock
Hiscox financial ratios help investors to determine whether Hiscox Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hiscox with respect to the benefits of owning Hiscox security.